Your browser doesn't support javascript.
loading
Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study.
Azoulay, Élie; Castro, Pedro; Maamar, Adel; Metaxa, Victoria; de Moraes, Alice Gallo; Voigt, Louis; Wallet, Florent; Klouche, Kada; Picard, Muriel; Moreau, Anne-Sophie; Van De Louw, Andry; Seguin, Amélie; Mokart, Djamel; Chawla, Sanjay; Leroy, Julien; Böll, Boris; Issa, Nahema; Levy, Bruno; Hemelaar, Pleun; Fernandez, Sara; Munshi, Laveena; Bauer, Philippe; Schellongowski, Peter; Joannidis, Michael; Moreno-Gonzalez, Gabriel; Galstian, Gennadii; Darmon, Michael; Valade, Sandrine.
Afiliación
  • Azoulay É; Critical Care Department, APHP, Hôpital Saint-Louis, University of Paris, Paris, France. Electronic address: elie.azoulay@aphp.fr.
  • Castro P; Medical Intensive Care Unit, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Maamar A; Critical Care and Infectious Diseases Department, Rennes University Hospital, Rennes, France; INSERM CIC-1414, Faculté de Médecine, Université Rennes 1, Rennes, France.
  • Metaxa V; Department of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.
  • de Moraes AG; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • Voigt L; Department of Anesthesiology, Pain, and Critical Care Medicine, Memorial Sloan Kettering Cancer Centre, New York City, NY, USA; Department of Anesthesiology, Weill Cornell Medical College, New York City, NY, USA.
  • Wallet F; Critical Care Department, HCL, Hôpital Lyon Sud, University of Lyon, Lyon, France.
  • Klouche K; Critical Care Department, Hôpital Lapeyronie, University of Montpellier, Montpellier, France.
  • Picard M; Critical Care Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Teaching Hospital of Toulouse, Toulouse, France.
  • Moreau AS; Critical Care Department, Lille University Salengro Hospital, Lille, France.
  • Van De Louw A; Division of Pulmonary and Critical Care Medicine, Penn State Health Milton S Hershey Medical Centre, Hershey, PA, USA.
  • Seguin A; Critical Care Department, Nantes University Hospital, Nantes, France.
  • Mokart D; Critical Care Department, Institut Paoli-Calmettes, Marseille, France.
  • Chawla S; Department of Anesthesiology, Pain, and Critical Care Medicine, Memorial Sloan Kettering Cancer Centre, New York City, NY, USA; Department of Anesthesiology, Weill Cornell Medical College, New York City, NY, USA.
  • Leroy J; Critical Care Department, APHP, Hôpital Saint-Louis, University of Paris, Paris, France.
  • Böll B; Department I of Internal Medicine, Haematology and Oncology, Intensive Care Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University of Cologne, Cologne, Germany.
  • Issa N; Critical Care Department, Hôpital Saint-André, University of Bordeaux, Bordeaux, France.
  • Levy B; Service de Médecine Intensive et Réanimation Brabois, CHRU Nancy, Pôle Cardio-Médico-Chirurgical, Vandoeuvre-les-Nancy, INSERM U1116, Faculté de Médecine, Vandoeuvre-les-Nancy, France.
  • Hemelaar P; Department of Intensive Care Medicine, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Fernandez S; Medical Intensive Care Unit, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Munshi L; Interdepartmental Division of Critical Care Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada.
  • Bauer P; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • Schellongowski P; Intensive Care Unit 13i2, Department of Medicine I, Medical University of Vienna, Centre of Excellence of Medical Intensive Care (CEMIC), Vienna, Austria.
  • Joannidis M; Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Moreno-Gonzalez G; Intensive Care Unit, Bellvitge University Hospital, Catalan Institute of Oncology L'Hospitalet, Bellvitge Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
  • Galstian G; Department of Intensive Care of the National Research Centre for Haematology, Moscow Russia.
  • Darmon M; Critical Care Department, APHP, Hôpital Saint-Louis, University of Paris, Paris, France.
  • Valade S; Critical Care Department, APHP, Hôpital Saint-Louis, University of Paris, Paris, France.
Lancet Haematol ; 8(5): e355-e364, 2021 May.
Article en En | MEDLINE | ID: mdl-33894170
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Síndromes de Neurotoxicidad / Síndrome de Liberación de Citoquinas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Síndromes de Neurotoxicidad / Síndrome de Liberación de Citoquinas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Año: 2021 Tipo del documento: Article